Patents by Inventor Michael A. Marks

Michael A. Marks has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IMAGING APPARATUS AND IMAGING METHOD FOR CAPTURING IMAGING DATA VIA A PIXEL ARRAY
    Publication number: 20170034464
    Abstract: The present disclosure relates to an imaging apparatus. The imaging apparatus comprises a pixel array. The pixel array comprises a first pixel comprising a first radiation-sensitive region and at least one associated charge storage region for collecting electrical charges from the first radiation-sensitive region. The pixel array also comprises a second pixel comprising a second radiation-sensitive region and at least one associated charge storage region for collecting electrical charges from the second radiation-sensitive region. Furthermore, the imaging apparatus comprises control circuitry configured to generate a common compensation signal being common to the first and second pixels. The common compensation signal mitigates a saturation of the respective charge storage regions of the first and second pixels.
    Type: Application
    Filed: June 29, 2016
    Publication date: February 2, 2017
    Inventors: Markus DIELACHER, Martin FLATSCHER, Stefan GANSINGER, Michael MARK, Josef PRAINSACK, Hartwig UNTERASSINGER
  • 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and thier use as pharmaceutical compositions
    Patent number: 9556175
    Abstract: The present invention relates to substituted xanthines of general formula wherein R1 to R3 are as defined herein, the tautomers, the stereoisomers, the mixtures, the prodrugs thereof and the salts thereof which have valuable pharmacological properties, particularly an inhibiting effect on the activity of the enzyme dipeptidylpeptidase-IV (DPP-IV).
    Type: Grant
    Filed: March 15, 2016
    Date of Patent: January 31, 2017
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Frank Himmelsbach, Elke Langkopf, Matthias Eckhardt, Michael Mark, Roland Maier, Ralf Lotz, Mohammad Tadayyon
  • PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
    Publication number: 20170020907
    Abstract: The invention relates to the treatment or prevention of one or more conditions selected from type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance and hyperglycemia using a SGLT-2 inhibitor. In addition the present invention relates to methods for preventing or treating of metabolic disorders and related conditions.
    Type: Application
    Filed: October 5, 2016
    Publication date: January 26, 2017
    Inventors: Peter EICKELMANN, Michael MARK, Leo John SEMAN, Leo THOMAS, Uli Christian BROEDL, Rolf GREMPLER
  • Use of a DPP-4 inhibitor in podocytes related disorders and/or nephrotic syndrome
    Patent number: 9526730
    Abstract: The present invention relates to methods for treating and/or preventing podocytes related disorders and/or nephrotic syndrome comprising the administration of an effective amount of a certain DPP-4 inhibitor, as well as to the use of a certain DPP-4 inhibitor for treating and/or preventing a metabolic disease in a patient with or at risk of podocytes related disorders and/or nephrotic syndrome.
    Type: Grant
    Filed: October 30, 2015
    Date of Patent: December 27, 2016
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Thomas Klein, Maximilian von Eynatten, Berthold Hocher, Michael Mark, Yuliya Sharkovska
  • TREATMENT OF GENOTYPED DIABETIC PATIENTS WITH DPP-IV INHIBITORS SUCH AS LINAGLIPTIN
    Publication number: 20160354380
    Abstract: The present invention relates to methods for preventing or treating of metabolic disorders and related conditions, such as in certain patient groups.
    Type: Application
    Filed: August 12, 2016
    Publication date: December 8, 2016
    Inventors: Klaus DUGI, Eva Ulrike GRAEFE-MODY, Michael MARK, Hans-Juergen WOERLE, Heike ZIMDAHL-GELLING
  • 1-[(3-CYANO-PYRIDIN-2-YL)METHYL]-3-METHYL-7-(2-BUTYN-1-YL)-8-[3-(R)-AMINO-PIPERIDIN-1-YL]-XANTHINE FOR THE TREATMENT OF A METABOLIC DISORDER OF A PREDOMINANTLY CARNIVOROUS NON-HUMAN ANIMAL
    Publication number: 20160346288
    Abstract: A method of treating a metabolic disorder or metabolic disease includes administering a pharmaceutically effective dose of 1-[(3-cyano-pyridin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-[3-(R)-amino-piperidin-1-yl]-xanthine, or a pharmaceutically acceptable salt thereof, to a predominantly carnivorous non-human animal in need thereof such that the severity of one or more clinical symptoms of the metabolic disorder or metabolic disease is reduced.
    Type: Application
    Filed: August 13, 2016
    Publication date: December 1, 2016
    Inventors: Frerich DE VRIES, Dirk HOERSTERMANN, Ingo LANG, Michael MARK, Randolph SEIDLER, Leo THOMAS
  • Photocatalytic teeth whitening
    Patent number: 9492257
    Abstract: The present disclosure relates to devices, methods and kits for accelerating the rate of whitening of teeth using an oxidizing agent, a photocatalytic agent, and a portable lightsource.
    Type: Grant
    Filed: September 3, 2014
    Date of Patent: November 15, 2016
    Assignee: Jasibo, LLC
    Inventors: Jennifer Jablow, Michael Mark Muehlemann
  • SYSTEMS AND METHODS FOR TIME OF FLIGHT MEASUREMENT USING A SINGLE EXPOSURE
    Publication number: 20160327638
    Abstract: A sensor array arrangement for a time of flight measurement system is disclosed. The arrangement includes a plurality of pixels and circuitry. The plurality of pixels are configured such that a first plurality of pixels receive a first reference signal and a second plurality of pixels receive a second reference signal. The first and second reference signals are phase shifted with respect to each other. The circuitry calculates depth information by combining information from first and second pixel sensor signals. The first pixel sensor signal is based on the first reference signal. The second pixel sensor signal is based on the second reference signal.
    Type: Application
    Filed: May 4, 2015
    Publication date: November 10, 2016
    Inventors: Markus Dielacher, Josef Prainsack, Martin Flatscher, Michael Mark, Hartwig Unterassinger
  • Treatment of genotyped diabetic patients with DPP-IV inhibitors such as linagliptin
    Patent number: 9457029
    Abstract: The present invention relates to methods for preventing or treating of metabolic disorders and related conditions, such as in certain patient groups.
    Type: Grant
    Filed: November 26, 2010
    Date of Patent: October 4, 2016
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Klaus Dugi, Eva Ulrike Graefe-Mody, Michael Mark, Hans-Juergen Woerle, Heike Zimdahl-Gelling
  • Electric machine housing
    Patent number: 9431881
    Abstract: A housing for enclosing electronics of a motor having an axis of rotation is provided. The housing includes an end cap having an outer surface and an inner surface. A control board is coupled to the inner surface, wherein the printed circuit board includes a first side, a second side and an edge located between the first side and the second side. The housing further includes a first circuit coupled to the first side which includes a plurality of first electrical components. Each first electrical component includes a tab extending beyond the edge. A second circuit is coupled to the second side and a fastener assembly is coupled to the tab and the inner surface.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: August 30, 2016
    Assignee: REGAL BELOIT AMERICA, INC.
    Inventors: David Allen Clendenen, Michael A. Marks, Peter B. Lytle, Harold Clifton Kingrey, Steven P. Richardville
  • PURIN DERIVATIVES FOR USE IN THE TREATMENT OF FAB-RELATED DISEASES
    Publication number: 20160206620
    Abstract: The present invention relates to the finding that certain DPP-4 inhibitors are particularly suitable for wound healing preferably in diabetic patients.
    Type: Application
    Filed: March 31, 2016
    Publication date: July 21, 2016
    Inventors: Thomas KLEIN, Michael MARK
  • Connector having a stabilizer in contact with a contact holder or an engagement member of a cable tray
    Patent number: 9391377
    Abstract: A connector includes a cable tray configured to receive and retain a cable in a stable position and couple with a top cap configured to create an electrical connection with the cable as the top cap is manipulated in a predetermined manner while coupled with the cable tray. An upper surface of the cable tray is configured to receive the cable. The cable tray also includes a finger extending beyond the first end for some distance longitudinally. The finger includes a protrusion that protrudes to some extent in a transverse direction so that a cable-accommodating gap is defined between the protrusion and the first end. The protrusion is configured to bear against the cable and retain the cable in the stable position when the cable is inserted between the protrusion and the first end (before, during and/or after an electrical connection is established).
    Type: Grant
    Filed: September 30, 2014
    Date of Patent: July 12, 2016
    Assignee: LOWE'S COMPANIES, INC.
    Inventors: Jean Tuck McGregor, James Michael Broughman, Allen R. Nelson, Darren Michael Mark, Laura Winfield Alexander, Donald Collins Meves
  • 8-[3-AMINO-PIPERIDIN-1-YL]-XANTHINES, THE PREPARATION THEREOF AND THEIR USE AS PHARMACEUTICAL COMPOSITIONS
    Publication number: 20160194327
    Abstract: The present invention relates to substituted xanthines of general formula wherein R1 to R3 are as defined herein, the tautomers, the stereoisomers, the mixtures, the prodrugs thereof and the salts thereof which have valuable pharmacological properties, particularly an inhibiting effect on the activity of the enzyme dipeptidylpeptidase-IV (DPP-IV).
    Type: Application
    Filed: March 15, 2016
    Publication date: July 7, 2016
    Inventors: Frank HIMMELSBACH, Elke LANGKOPF, Matthias ECKHARDT, Michael MARK, Roland MAIER, Ralf LOTZ, Mohammad TADAYYON
  • PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
    Publication number: 20160158264
    Abstract: The invention relates to the treatment or prevention of one or more conditions selected from type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance and hyperglycemia using a SGLT-2 inhibitor. In addition the present invention relates to methods for preventing or treating of metabolic disorders and related conditions.
    Type: Application
    Filed: February 18, 2016
    Publication date: June 9, 2016
    Inventors: Peter EICKELMANN, Michael MARK, Leo John SEMAN, Leo THOMAS, Uli Christian BROEDL, Rolf GREMPLER
  • TRANSCEIVER DEVICE, ACCESS CONTROL DEVICES, A TRANSMITTER DEVICE AND A RECEIVER DEVICE
    Publication number: 20160156419
    Abstract: A transceiver device includes a time of flight circuit configured to emit a modulated light transmit signal and to receive a modulated light receive signal. The transceiver device includes a control module configured to control a transmission of a modulated light transmit signal by the time of flight circuit to an access control device. The modulated light transmit signal includes information related to a transmission access request. The control module is further configured to control an establishment of a wireless transmission channel based on a modulated light receive signal received by the time of flight circuit from the access control device. The modulated light receive signal includes information for establishing the wireless transmission channel.
    Type: Application
    Filed: December 1, 2014
    Publication date: June 2, 2016
    Inventors: Norbert Druml, Armin Krieg, Markus Dielacher, Robert Lobnik, Michael Mark
  • ACCESS CONTROL DEVICES AND A TRANSCEIVER DEVICE
    Publication number: 20160156420
    Abstract: An access control device includes a time of flight circuit configured to determine a distance information related to a distance between the access control device and a peripheral device. The access control device further includes a control module configured to control a transmission of a modulated light transmit signal by the time of flight circuit to the peripheral device. The modulated light transmit signal includes the distance information determined by the time of flight circuit of the access control device.
    Type: Application
    Filed: July 27, 2015
    Publication date: June 2, 2016
    Inventors: Norbert Druml, Armin Krieg, Markus Dielacher, Robert Lobnik, Michael Mark, Josef Haid
  • PURIN DERIVATIVES FOR USE IN THE TREATMENT OF FAB-RELATED DISEASES
    Publication number: 20160136180
    Abstract: The invention is directed to the use of selected purine derivatives for the treatment of hyperproliferative diseases.
    Type: Application
    Filed: January 20, 2016
    Publication date: May 19, 2016
    Inventors: Frank Himmelsbach, Michael Mark, Mohammad Tadayyon, Leo Thomas
  • DEVICE FOR HANGING OBJECTS
    Publication number: 20160128497
    Abstract: A device for hanging an object on a wall includes a crossbar, a knuckle, an arm, and an end cap. The crossbar includes a track extending between two opposing ends of the crossbar. The knuckle is slidably coupled to the crossbar such that the knuckle is slidable in a first direction. The knuckle includes a projection that has a pair of parallel sides. The arm has a marking pin that projects generally perpendicular from a forward surface of the arm. The arm is coupled to the crossbar via the knuckle such that the arm is slidable along the pair of parallel sides of the projection in a second direction. The end cap is coupled to one of the two opposing ends of the crossbar. The end cap includes an “L” bracket that provides an engagement surface for engaging a corner of a second object previously hung on the wall.
    Type: Application
    Filed: January 15, 2016
    Publication date: May 12, 2016
    Inventor: Michael A. Marks
  • 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
    Patent number: 9321791
    Abstract: The present invention relates to substituted xanthines of general formula wherein R1 to R3 are as defined herein, the tautomers, the stereoisomers, the mixtures, the prodrugs thereof and the salts thereof which have valuable pharmacological properties, particularly an inhibiting effect on the activity of the enzyme dipeptidylpeptidase-IV (DPP-IV).
    Type: Grant
    Filed: June 24, 2015
    Date of Patent: April 26, 2016
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Frank Himmelsbach, Elke Langkopf, Matthias Eckhardt, Michael Mark, Roland Maier, Ralf Lotz, Mohammad Tadayyon
  • Handle for a vehicle
    Patent number: D772682
    Type: Grant
    Filed: October 23, 2014
    Date of Patent: November 29, 2016
    Assignee: Caterpillar Inc.
    Inventors: Jason Edward Stibs, Michael Eugene Lee, Michael Mark Conrad, Michael Scott Hemry, Gregory James Parsons